Regulus Therapeutics Inc (NASDAQ:RGLS)
| 0.2325 Delayed Data As of Jun 24 |  -0.0276 / -10.61%Today’s Change | 0.16 Today|||52-Week Range 1.05 | -26.19% Year-to-Date |
Latest RGLS News | Press Releases
No recent news for Regulus Therapeutics Inc.
Today’s Trading
| Previous close | 0.26 |
| Today’s open | 0.27 |
| Day’s range | 0.23 - 0.27 |
| Volume | 66,382 |
| Average volume (3 months) | 1,832,685 |
| Market cap | $35.1M |
Data as of 4:00pm ET, 06/24/2022
Growth & Valuation
| Earnings growth (last year) | +27.84% |
| Earnings growth (this year) | +39.30% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -100.00% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.64 |
Competitors
| ---- | ||
| ERYPErytech Pharma SA | +0.01 | +0.88% |
| TNXPTonix Pharmaceutical... | -0.11 | -5.53% |
| ABIOARCA Biopharma Inc | -0.04 | -1.58% |
Data as of 4:24pm ET, 06/24/2022
Financials
| Next reporting date | August 11, 2022 |
| EPS forecast (this quarter) | -$0.05 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$27.8M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters San Diego, California |
Forecasts
